drugset / Trial / NCT00002195
A Study of Retrovir and Epivir Alone or in Combination With 141W94 in HIV-Infected Patients
Parallel-groupTreatment
Summary
The purpose of this study is to see if it is safe and effective to add 141W94 to an anti-HIV regimen that includes retrovir plus epivir.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amprenavir | Other / unclassified | — | — |
| Background | Lamivudine | Other / unclassified | — | — |
| Background | Zidovudine | Small molecule | — | — |